Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Ohno

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
NPJ Systems Biology and Applications|September 30, 2024
Time and dose selective glucose metabolism for glucose homeostasis and energy conversion in the liverYifei Pan, Atsushi Hatano, Satoshi Ohno, et al.
Science Signaling|April 22, 2025
Structural robustness and temporal vulnerability of the starvation-responsive metabolic network in healthy and obese mouse liverKeigo Morita, Atsushi Hatano, Toshiya Kokaji, et al.
Iscience|March 25, 2024
Trans-omic analysis reveals opposite metabolic dysregulation between feeding and fasting in liver associated with obesityYunfan Bai, Keigo Morita, Toshiya Kokaji, et al.
BMC Biotechnology|April 8, 2016
Escherichia coli-based production of recombinant ovine angiotensinogen and its characterization as a renin substrateShinji Yamashita, Naoya Shibata, Akiyoshi Boku-Ikeda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2021
Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian CancerSumiyuki Nishida, Soyoko Morimoto, Yusuke Oji, et al.
International Journal of Hematology|January 15, 2008
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myelomaAkihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, et al.
Scientific Reports|November 5, 2023
DNA hypomethylation characterizes genes encoding tissue-dominant functional proteins in liver and skeletal muscleHideki Maehara, Toshiya Kokaji, Atsushi Hatano, et al.
Journal of Neurosurgery|May 2, 2008
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiformeShuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, et al.
Scientific Reports|August 12, 2022
In vivo transomic analyses of glucose-responsive metabolism in skeletal muscle reveal core differences between the healthy and obese statesToshiya Kokaji, Miki Eto, Atsushi Hatano, et al.
Japanese Journal of Clinical Oncology|April 14, 2006
A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I dataSatoshi Morita, Yoshihiro Oka, Akihiro Tsuboi, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
NPJ Systems Biology and Applications|September 30, 2024
Time and dose selective glucose metabolism for glucose homeostasis and energy conversion in the liverYifei Pan, Atsushi Hatano, Satoshi Ohno, et al.
Science Signaling|April 22, 2025
Structural robustness and temporal vulnerability of the starvation-responsive metabolic network in healthy and obese mouse liverKeigo Morita, Atsushi Hatano, Toshiya Kokaji, et al.
Iscience|March 25, 2024
Trans-omic analysis reveals opposite metabolic dysregulation between feeding and fasting in liver associated with obesityYunfan Bai, Keigo Morita, Toshiya Kokaji, et al.
BMC Biotechnology|April 8, 2016
Escherichia coli-based production of recombinant ovine angiotensinogen and its characterization as a renin substrateShinji Yamashita, Naoya Shibata, Akiyoshi Boku-Ikeda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 7, 2021
Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian CancerSumiyuki Nishida, Soyoko Morimoto, Yusuke Oji, et al.
International Journal of Hematology|January 15, 2008
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myelomaAkihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, et al.
Scientific Reports|November 5, 2023
DNA hypomethylation characterizes genes encoding tissue-dominant functional proteins in liver and skeletal muscleHideki Maehara, Toshiya Kokaji, Atsushi Hatano, et al.
Journal of Neurosurgery|May 2, 2008
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiformeShuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, et al.
Scientific Reports|August 12, 2022
In vivo transomic analyses of glucose-responsive metabolism in skeletal muscle reveal core differences between the healthy and obese statesToshiya Kokaji, Miki Eto, Atsushi Hatano, et al.
Japanese Journal of Clinical Oncology|April 14, 2006
A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I dataSatoshi Morita, Yoshihiro Oka, Akihiro Tsuboi, et al.
Pageof 17